Keywords: peregrine, gets, indian, ok, ph, ii, nsclc

Peregrine gets Indian OK for Ph II NSCLC trial

Article | 28 January 2008

Print This

US biopharmaceutical firm Peregrine Pharmaceuticals says that its protocol for a Phase II study of bavituximab in non-small cell lung ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in